Novonesis
Claus Crone Fuglsang serves as the Chief Scientific Officer and Executive Vice President at Novonesis, bringing extensive experience from previous leadership roles. At Novozymes North America Inc., Claus held the position of Vice President of BioEnergy R&D, focusing on innovative research and development in biotechnology. Additionally, Claus has experience as Managing Director at Novozymes Inc., contributing to the advancement of sustainable solutions in the industry.
This person is not in any teams
This person is not in any offices
Novonesis
41 followers
At Novonesis, we believe solutions rooted in biology are key to tackling the challenges our world faces. Enzymes, functional proteins and microorganisms are our planet's tiniest, yet mightiest agents of change. When we leverage their power with science, we create biosolutions that transform the way we all produce, consume and live. Today, we are 10,000 people worldwide whose expertise spans more than 30 different industries. All around the world our biosolutions already create value for thousands of customers and benefit the planet. Our solutions enable feeding and fueling the world more sustainably, from healthy and sustainable nutrition to biofuel. Biosolutions also reduce the use of fossil-based resources, chemicals, energy and water. And this is just the beginning. The potential is almost endless. The time for biosolutions is now. And by working closely with our partners and customers, we will continue to challenge conventional thinking and transform business with biology. Together, we will create the change our world needs. Let’s better our world with biology.